BridgeBio Oncology Therapeutics Inc. (BBOT) Financials
BBOT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 417.6 million | 45.4 million |
| Dec. 31, 2025 | 448.4 million | 37.3 million |
| Sept. 30, 2025 | 484.8 million | 38.1 million |
| June 30, 2025 | 151.3 million | 379.0 million |
BBOT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -35.9 million | 3.9 million |
| Dec. 31, 2025 | -42.3 million | 2.9 million |
| Sept. 30, 2025 | -71.2 million | 2.8 million |
| June 30, 2025 | -23.5 million | 875000 |
BBOT Net Income
No data available :(
BBOT Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 252.3 million | - | 2.1 million |
| Dec. 31, 2025 | 425.5 million | 2.2 million | 2.8 million |
| Sept. 30, 2025 | 468.3 million | - | 2.9 million |
| June 30, 2025 | 131.4 million | - | 2.8 million |
BBOT Shares Outstanding
BBOT Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 24000 | 39.8 million | 6.4 million | - |
| Dec. 31, 2025 | 73000 | 38.1 million | 5.3 million | - |
| Sept. 30, 2025 | 532996 | 35.1 million | 14.1 million | - |
| June 30, 2025 | 231000 | 27.4 million | 2.7 million | - |
BBOT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 186000 |
| Dec. 31, 2025 | - | 194000 |
| Sept. 30, 2025 | - | - |
| June 30, 2025 | - | - |
BBOT
Price: $7.67
52 week price:
Earnings Per Share: -1.92 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 581.6 million